BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20500687)

  • 1. Evidence for immunosurveillance in intestinal premalignant lesions.
    Karlsson M; Lindberg K; Karlén P; Ost A; Thörn M; Winqvist O; Eberhardson M
    Scand J Immunol; 2010 May; 71(5):362-8. PubMed ID: 20500687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sentinel node technique is useful for studies of intestinal immunology in inflammatory bowel disease patients.
    Eberhardson M; Lindberg K; Karlsson M; Karlén P; Winqvist O; Thörn M
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):985-8. PubMed ID: 18787465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients].
    Wang S; Fan P; Wu ZY
    Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis.
    Schneider A; Stolte M
    Z Gastroenterol; 1993 Nov; 31(11):653-6. PubMed ID: 8291276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.
    Hultkrantz S; Ostman S; Telemo E
    Immunology; 2005 Nov; 116(3):362-72. PubMed ID: 16236126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis.
    Simpson SJ; Mizoguchi E; Allen D; Bhan AK; Terhorst C
    Eur J Immunol; 1995 Sep; 25(9):2618-25. PubMed ID: 7589135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
    Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
    Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity.
    Awais D; Siegel CA; Higgins PD
    Gut; 2009 Nov; 58(11):1498-503. PubMed ID: 19651634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common TCR beta-chain expressed by CD8+ intestinal mucosa T cells in ulcerative colitis.
    Chott A; Probert CS; Gross GG; Blumberg RS; Balk SP
    J Immunol; 1996 Apr; 156(8):3024-35. PubMed ID: 8609425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts.
    Ciabattini A; Pettini E; Arsenijevic S; Pozzi G; Medaglini D
    Vaccine; 2010 Feb; 28(5):1226-33. PubMed ID: 19945415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.